Bd Nexiva Closed Iv Catheter System

KIT START STATLOCK NEXIVA LF50/CS
Key Features
  • SKU: BDM-IVK0175
  • Condition: Factory New
  • Weight: 3.55 lb
  • Nexiva StatLock IV Start Kit, Includes: Alcohol Prep Pack, ChloraPrep 1.0 mL Applicator, 3M Tegaderm IV Nonsterile Dressing (2 3/8" x 2 ¾"), Gauze (2" x 2"), IV Label for Start Kits, Tourniquet, Latex-Free, 50/cs (Drop Ship Requires Pre-Approval)

  • Learn more:

Contact The Manufacturer
  • MFR: BD Ships from MFI Medical
  • MPN: IVK0175
  • Phone: (877) 232-8995
$440.09

+Free Shipping*

4+ In Stock

Est. Delivery:
%3Cp%3EEarn%20[points_amount]%20when%20you%20buy%20this%20item.%3C/p%3E

Shop with Confidence

Free Shipping

+

Free Returns

Payment Options

+

Price Match Guarantee

Sales Tax Exemption

+

Dedicated Account Managers

Description

BD . A pre-assembled system that creates a closed single lumen fluid path, designed to minimize blood leakage from the catheter hub, and the potential for contamination and exposure to blood. A second port allows for simultaneous administration of compatible fluids and medications near the insertion site. The integrated, soft, flexible stabilization platform is designed for stability and comfort, and to minimize catheter movement in the vessel, as well as irritation to the vessel. Made of clinically proven BD Vialon biomaterial.

Frequently asked questions

Does the closed system improve safety?

Yes, the BD Nexiva Closed IV Catheter System features a closed system design that significantly enhances safety for both clinicians and patients by:

  • Minimizing blood leakage: This reduces potential exposure to blood.
  • Reducing contamination risk: By maintaining a closed fluid path, it helps ensure a sterile environment during IV procedures.
Does the stabilization platform enhance comfort?

Yes, the BD Nexiva Closed IV Catheter System features an integrated, soft, and flexible stabilization platform designed to provide stability and comfort. This platform helps to:

  • Minimize catheter movement within the vessel
  • Reduce irritation to the vessel

These features work together to enhance patient comfort during IV therapy.

Does it allow simultaneous fluid administration?

Yes, the BD Nexiva Closed IV Catheter System features a secondary port located near the insertion site. This allows for the simultaneous administration of compatible fluids and medications, which helps to streamline the IV process.

What high-quality biomaterial is used in the BD Nexiva catheter?

The BD Nexiva catheter is made from BD Vialon biomaterial, a clinically proven material known for its biocompatibility and optimal performance. This material ensures reliability and patient safety during use.

Is the catheter system pre-assembled?

Yes, the BD Nexiva Closed IV Catheter System is designed as a pre-assembled unit. This ready-to-use design helps streamline the IV insertion process.

Is the stabilization platform comfortable?

The integrated stabilization platform is crafted to be soft and flexible. This design helps minimize catheter movement within the vessel and reduces vessel irritation, enhancing patient comfort.

How does it prevent blood leakage?

The BD Nexiva system creates a closed, single-lumen fluid path. This design minimizes blood leakage from the catheter hub, significantly reducing the potential for contamination and exposure to blood during use.

What is the weight of the catheter system package?

The weight specified for this variant of the Bd Nexiva Closed IV Catheter System, which includes 50 kits per case, is 0.01 pounds.

Does it include all necessary start kit components?

Yes, the Bd Nexiva Closed IV Catheter System comes with a comprehensive StatLock IV Start Kit. It includes:

  • Alcohol Prep Pack
  • ChloraPrep 1.0 mL Applicator
  • 3M Tegaderm IV Nonsterile Dressing (2 3/8” x 2 ¾”)
  • Gauze (2” x 2”)
  • IV Label for Start Kits
  • Tourniquet
Is the system latex-free for patient safety?

Yes, the Bd Nexiva Closed IV Catheter System and its associated StatLock IV Start Kit are Latex-Free, prioritizing patient safety and reducing the risk of allergic reactions.